MUSC Hollings Cancer Center researcher Haizhen (Jen) Wang, Ph.D., was awarded a five-year $344,000 per year grant by the National Cancer Institute to pursue her early investigator studies in leukemia.
MUSC Hollings Cancer Center researcher Haizhen (Jen) Wang, Ph.D., recently was awarded a three-year $225,000 Young Investigator grant from the Melanoma Research Alliance.
researcher Haizhen (Jen) Wang, Ph.D., recently was awarded a three-year $225,000 Young Investigator grant from the Melanoma Research Alliance.
MRA research awards support innovative ideas that offer the promise of rapidly improving outcomes for patients facing melanoma. Each award was selected during MRA’s grant review through a rigorous peer review process and was confirmed by the MRA Board of Directors. The alliance, the largest nonprofit funder of melanoma research, announced $8.1 million in funding for 34 new awards that support research at 27 institutions in seven countries.
MRA chief science officer Marc Hurlbert, Ph.D., said in the company’s press release that MRA grant awards support scientists who are pushing the envelope in order to address some of the biggest unanswered questions in melanoma. “These include researchers working on modulating the microbiome to improve patient outcomes and others exploring strategies to understand and overcome resistance to therapies
MUSC Hollings Cancer Center researcher Haizhen (Jen) Wang, Ph.D., recently was awarded a three-year $225,000 Young Investigator grant from the Melanoma Research Alliance. The grant will help Wang further her research on T-cells and the tumor microenvironment in melanoma patients.